Interestingly, the authors discovered that ALL-mediated induction of TIM-3 on T cells is mediated by CD200, yet another immune checkpoint molecule; however, the precise mechanism how CD200 augments TIM-3 expression needs further evaluation. Here, HAVCR2 is linked to acute lymphoblastic leukemia.